AcesoStem Biostrategies
Seoul, South Korea
◆ Total Raised
$2.6M
◆ Stage
series-a
◆ Location
Seoul, South Korea
◆ Founded
2019
◆ About AcesoStem Biostrategies
South Korean startup developing cell therapies for musculoskeletal diseases including rotator cuff tears and osteoarthritis.
◆ What sets it apart
It focuses on stem-cell and cell-tuning technologies for difficult musculoskeletal conditions, including an injectable cell delivery platform and rotator cuff/osteoarthritis pipelines.
◆ Sectors
◆ Business
Modelhardware
CustomerHospitals, clinicians, and patients seeking regenerative treatments for musculoskeletal diseases
◆ Notable
- Raised KRW 4 billion in Series A funding in June 2026
- Advanced a rotator cuff program into Phase 1/2a clinical development
- Reported first-in-human-style clinical evidence of rotator cuff regeneration in a Phase 1 study of its lead program
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does AcesoStem Biostrategies do?
South Korean startup developing cell therapies for musculoskeletal diseases including rotator cuff tears and osteoarthritis.
Where is AcesoStem Biostrategies based?
AcesoStem Biostrategies is based in Seoul, South Korea, founded in 2019.
How much has AcesoStem Biostrategies raised?
AcesoStem Biostrategies has raised $2.6M in tracked funding and is currently at the series-a stage.
Who has invested in AcesoStem Biostrategies?
Investors in AcesoStem Biostrategies include Premier Partners, Seoul Technology Holdings, BlissVine Ventures and Tap Angel Partners.